Fig. 4From: Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2Percent change in xenograft volume over time. a Percent change over time 177Lu-m11B6 and controls. b. Zoomed in, the change during the first 60 days of 177Lu-m11B6 treatment. c Tumor growth development in percent for DU 145 xenografts for mice given 24 ± 0.45 MBq 177Lu-m11B6 and NaCl, respectivelyBack to article page